Laser Assisted Therapies and Immunotherapies for Oncology
Assisted Laser Therapies and Immunotherapies for Oncology
Professor Vanderlei Salvador Bagnato has a PhD from MIT (1987). He graduated with Honors, at the same time, in Materials Engineering (Federal University of São Carlos - Brazil - 1981) and in [...]
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
On November 8th and 9th, 2018, the Cancéropole Nord-Ouest organized the second edition of the "Translationnelles" days: "Ovarian cancer - from biology to clinic" in Caen, France.
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Third place for OncoThAI
The thesis project "Design of a light emitting fabric dedicated to intracavitary photodynamic therapy" received a favorable opinion from the ANRT for CIFRE funding.
OncoThAI will attend the 18th Congress of the European Society for Photodynamic Therapy in Brussels, France On March 8th and 9th 2019.
Martha Baydoun, a postdoctoral fellow, has been selected by the call for projects Mobility to develop this research.
The thesis project "Development of a light emitting fabric for the treatment of peritoneal carcinomatosis of ovarian origin by intracavitary photodynamic therapy" received the favorable opinion of [...]
Matthieu DURAND, Urologist, defended his thesis entitled "EX VIVO 7 TESLA EXPERIMENTAL IMAGING OF LOCALIZED CANCER OF THE PROSTATE" on July 9, 2019.
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
Pr. Nicolas Reyns will present our latest breakthroughs in the glioblastoma treatment.
Under the chairmanship of Professor Pierre COLLINET, this congress will propose a program combining the fundamentals of surgery with the most striking innovations.
Congratulations to Ludivine LARUE, Isabelle TOUBIA and Mathilde CHAMPEAU for their brilliant presentations of their research work.
Prof. Mortier presented this technology on Europe 1 radio
"Diagnostic and therapeutic strategies for intracranial vascular pathologies"
The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy & specificities for the physicians
Back
